The role of phonophoresis on patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial

The role of phonophoresis on patients with chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033589

Enrollment

Unknown

Registered

2020-06-06

Start date

2020-06-05

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

experimental group:phonophoresis

control group:usual care

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inpatients with COPD; 2. Patients who are conscious, have stable vital signs and can cooperate with each other; 3. Patients whose sputum viscosity degree is II or III; 4. Patients who have obtained informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with neuromuscular disease or end-stage disease; 2. Patients with asthma or other respiratory diseases; 3. Patients with thoracoabdominal trauma or operation; 4. Patients with skin infection at the contact site; 5. Patients with pacemaker, artificial stent, artificial valve, etc.

Design outcomes

Primary

Measure	Time frame
sputum vistory;sputum volume;VC;FEV1/FVC;spo2;	—

Secondary

Measure	Time frame
CAT score;AIR score;	—

Countries

China

Contacts

Public ContactFeng Li

College of Nursing, Jilin University

fli@jlu.edu.cn+86 17790089009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026